Molecular biology of soft-tissue sarcomas;Biologie moléculaire des sarcomes

Bulletin du Cancer

Volumn 97, Issue 11, 2010, Pages 1337-1345

  Coindre, J M ^a  

^a INSERM   (France)

Author keywords

Activating mutation; Amplification; Molecular biology; Sarcomas; Translocation

Indexed keywords

CYCLIN DEPENDENT KINASE 4; IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN MDM2; PROTEIN P53; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR;

FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL STROMAL TUMOR; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE PROBE; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MOLECULAR BIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

EID: 78650115560     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1213     Document Type: Review

References (21)

1. In : Fletcher CDM, Unni K, Mertens F, eds. World Health Organization Classification of tumours. Pathology and genetic. Tumours of soft tissue and bone. Lyon : IARC Press, 2002.
2. Antonescu C. The role of genetic testing in soft tissue sarcoma. Histopathology 2006 ; 48 : 13-21.
3. Coindre JM, Sigaux F, Delsol G. Tumorothèque à visée sanitaire : définition, intérêts et recommandations. Bull Cancer 2006 ; 93 : S213-220.
4. Aurias A, Rimbaut C, Buffe D, Dubousset J, Mazabraud A. Translocation of chromosome 22 in Ewing's sarcoma. CR Seances Acad Sci III 1983 ; 296 : 1105-7.
5. Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir G. Chromosomal translocation (11;22) in cell of Ewing's sarcoma. CR Seances Acad Sci III 1983 : 1101-3. (Pubitemid 14226798)
6. Riggi N, Cironi L, Suvà ML, Stamencovic I. Sarcomas: genetics, signalling, and cellular origins Part 1: the fellowship of TET. J Pathol 2007 ; 213 : 4-20. (Pubitemid 47354561)
7. Suvà ML, Cironi L, Riggi N, Stamencovic I. Sarcomas: genetics, signalling, and cellular orignins. Part 2: TET-independent fusion proteins and receptor tyrosine-kinase mutations. J Pathol 2007 ; 213 : 117-30. (Pubitemid 47612234)
8. Tanas MR, Goldblum JR. Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasm: a review. Adv Anat Pathol 2009 ; 16 : 383-91.
9. Williamson D, Missiaglia E, de Reyniès A, Pierron G, Thuille B, Palenzuela G, et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010 ; 28 : 2126-8.
10. Coindre JM, Pédeutour F, Aurias A. Well-differentiated and dedifferentiated liposarcomas. Virchows Arch 2010 ; 456 : 167-79.
11. Mariani O, Brennetot C, Coindre JM, Ganem C, Gruel N, Delattre O, et al. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 2007 ; 11 : 361-74. (Pubitemid 46518313)
12. Bui Nguyen Binh M, Sastre-Garau X, Guillou L, de Pinieux G, Terrier PH, Lagacé R, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes. A comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005; 29: 1340-7. (Pubitemid 41368770)
13. Sirvent N, Coindre JM, Maire G, Hostein I, Keslair F, Guillou L, et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol 2007 ; 31 : 1476-89. (Pubitemid 47482460)
14. Coindre JM, Mariani O, Chibon F, Mairal A, de Saint-Aubain Somerhausen N, Favre-Guillevin E, et al. Most malignant fibrous histiocytomas developed in the retroperitoneun are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 2003 ; 16 : 256-62. (Pubitemid 36337432)
15. Rubin BP. Gastrointestinal stromal tumours: an update. Histopathology 2006 ; 48 : 83-96.
16. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998 ; 279 : 577-80. (Pubitemid 28067289)
17. Agaram NP, Wong GC, Guo T, Maki RG, Singer S, Dematteo RP, et al. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 2008 ; 47 : 853-9.
18. Italiano A, Bui B. Aspects moléculaires et stratégies thérapeutiques des tumeurs stromales gastro-intestinales. Bull Cancer 2008 ; 95 : 107-16. (Pubitemid 351262489)
19. Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol 2007 ; 211 : 323-30. (Pubitemid 46172708)
20. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol 2009 ; 33 : 542-50.
21. Guillou L, Aurias A. Soft tissue sarcomas with complex genomic profiles. Virchows Arch 2010 ; 456 : 201-17.